Finance

Results: 433-444 of 44417

Shanghai - New York: to Become a Benchmark for China-U.S. Subnational Cooperation

PR Newswire associated0

Bayer Foundation Women Entrepreneurs Award: From AI Diagnostics to Circular Food Tech, 15 Women Are Transforming Health and Food Systems Worldwide

Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient

ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows

Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions

AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada

Luxfer Declares Quarterly Dividend

Vertex to Acquire Crinetics Pharmaceuticals

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

Lone Star Funds Announces Agreement to Acquire ContiTech, the Material Solutions Group of Continental AG

CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine

EDITORIAL USE ONLY Rahim Rahmani, Pharmacy Manager, gives Olufunmilayo Akinlolu Superdrug’s new oral weight loss drug at the Strand store in London, as the retailer becomes the first UK pharmacy to offer the treatment at more than 160 branches nationwide, with prices starting from £79 for new patients. Picture date: Monday July 6, 2026. PA Photo.

First UK patient accesses new weight loss service as Superdrug becomes the first high street pharmacy to provide service